Adamas Pharma Cash Flow - Quarterly (NASDAQ:ADMS)

Add to My Stocks
$27.1 $0.65 (2.46%) ADMS stock closing price Mar 16, 2018 (Closing)

The financial analysis of ADMS requires an investor to check the cash flows for Adamas Pharma. While its important to look at the Adamas Pharma debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as Adamas Pharma revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. Adamas Pharma saw a cash impact of $3.19M from the issuance of ADMS shares. The cash flow statement helps in the Adamas Pharma stock analysis by providing more information for evaluating changes in assets, liabilities and equities. Adamas Pharma saw a inflow of $2.79M from investing activities till 2017 Q3.

View and download details of Adamas Pharma cash flows for latest & last 40 quarters
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q3
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow1.1M-------1.15M
Net Increase (Decrease) in Assets Liabilities5.24M2.27M-1.29M--1.35M--1.62M-6.67M-2.12M
Cash From (used in) Discontinued Operations---------
Other Adjustments Net11.78M7.37M2.88M10.57M7.78M5.18M2.55M10.83M7.2M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.93M-0.62M-0.36M-1.62M-1.22M-1.24M-0.46M-1.39M-1.13M
Acquisition Disposition of Subsidiaires---------
Increase (Decrease) in Investments3.72M1.02M10.8M-25.08M-48.73M37.65M16.07M9.45M1.16M
Other Cash Inflow (Outflow) from Investment Activities---------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares3.19M1.2M-64.78M64.74M63.94M62.19M10.4M10.32M
Issuance (Repayment) of Debt Securities34.6M34.6M-------
Increase (Decrease) in Bank & Other Borrowings---------
Payment of Dividends & Other Cash Distributions---------
Other Cash from (used by) Financing Activities-0.19M--------
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash---------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year33.1M61.44M85.61M62.95M3.11M----
Cash & Equivalents at Year End22.12M33.61M20.91M23.73M9.77M109.27M98.4M33.1M37.11M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

While Adamas Pharma stock price history provides the price history of a stock, Adamas Pharma stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:

  • Adamas Pharma has cash of $22.12M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the Adamas Pharma stock price.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a negative value of $-42M for ADMS.
  • Cash from investing stood at a positive value of $2.79M for ADMS stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. Adamas Pharma earned $37.59M from financing activities,in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For Adamas Pharma Cash Flow

Quarterly Cash Flow Statements For Adamas Pharmaceuticals Inc Peers

Acadia Pharma cash flow, Cymabay cash flow, GlaxoSmithKline cash flow, Merck cash flow, Voyager Therapeutics cash flow